Legal Representation
Attorney
JANET G RICCIUTI
USPTO Deadlines
Next Renewal Deadline
113 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-10-29)
Due Date
October 29, 2025
Grace Period Ends
April 29, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
24 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 4, 2025 | E815 | I | TEAS SECTION 8 & 15 RECEIVED |
| Oct 29, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Oct 29, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Sep 27, 2019 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Sep 26, 2019 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Sep 23, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sep 23, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Sep 23, 2019 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
| Sep 17, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Sep 17, 2019 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Aug 20, 2019 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Aug 20, 2019 | IUAF | S | USE AMENDMENT FILED |
| Mar 19, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 15, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Mar 15, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 15, 2019 | EXT1 | S | SOU EXTENSION 1 FILED |
| Sep 25, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jul 31, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jul 31, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jul 11, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jun 27, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 25, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 20, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 17, 2018 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Therapeutic pharmaceuticals for the treatment of remyelination, diseases of Multiple Sclerosis, and the treatment of cancer
First Use Anywhere:
May 16, 2019
First Use in Commerce:
May 16, 2019
Classification
International Classes
005